Literature DB >> 16038389

Procalcitonin is useful whereas C-reactive protein is not, to predict complications following coronary artery bypass surgery.

Francesco Macrina1, Luigi Tritapepe, Francesca Pompei, Alfonso Sciangula, Ernesto Evangelista, Francesca Toscano, Anna Criniti, Gianluca Brancaccio, Paolo Emilio Puddu.   

Abstract

BACKGROUND: The respective value of procalcitonin (PCT) and C-reactive protein (CRP) as markers of postoperative complications after coronary bypass surgery is unclear. Therefore, complications during one week after surgery were studied to evaluate the predictive role of PCT and CRP changes during the immediate postoperative period.
METHODS: Thirty-two patients, in whom an uneventful immediate postoperative course was anticipated, were prospectively enrolled and followed-up to the 7th postoperative day. At the end of the follow-up, patients were divided into two groups. Group A were patients with an uncomplicated postoperative course and Group B were patients with a complicated postoperative course.
RESULTS: Serum samples were drawn for PCT and CRP determination after induction of anesthesia (baseline), at the end of surgery and daily until postoperative day 2. Baseline serum PCT concentrations were 0.11 +/- 0.09 and 0.20 +/- 0.21 ng/mL in Groups A and B, respectively (NS). Serum PCT concentration increased compared with baseline in both groups during the first two days after surgery. The increase in serum PCT concentration was significantly greater in Group B than A patients (p < 0.0002). Considering a perioperative abnormal cut-off value of >0.5 ng/mL, there were none in Group A versus 57% in Group B (p < 0.0001). Baseline serum CRP concentrations were 1.44 +/- 1.30 and 1.58 +/- 1.35 ng/mL in Groups A and B, respectively (NS). After surgery, CRP increased significantly compared with baseline in both groups. When changes in time-varying variables were included in a logistic model, complications were predicted by changes (between baseline and end of surgery values) of PCT (coefficient = 9.410; t = 2.18) and heart rate (coefficient = 0.075; t = 1.57), whereas changes of CRP, white blood cells, mean blood and central venous pressures did not contribute statistically. The model constant was -4.827 (t = -2.43) and the ROC curve area was 0.8971. Thus, absolute PCT changes of 0.20, 0.40 and 0.60 ng/mL carry an approximate risk of 5, 26 and 69%, respectively, of postoperative complications in the time frame of this study.
CONCLUSIONS: A postoperative serum PCT concentration of >0.5 ng/mL is highly suggestive of a postoperative complication. CRP changes do not contribute to predictive information.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16038389     DOI: 10.1191/0267659105pf800oa

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  8 in total

Review 1.  Procalcitonin: present and future.

Authors:  H H Liu; J B Guo; Y Geng; L Su
Journal:  Ir J Med Sci       Date:  2015-07-10       Impact factor: 1.568

Review 2.  Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature.

Authors:  Christoph Sponholz; Yasser Sakr; Konrad Reinhart; Frank Brunkhorst
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

3.  Markedly elevated procalcitonin in early postoperative period in pediatric open heart surgery: a prospective cohort study.

Authors:  Etsuko Minami; Shoji Ito; Takeshi Sugiura; Yoshihito Fujita; Hiroshi Sasano; Kazuya Sobue
Journal:  J Intensive Care       Date:  2014-06-20

4.  Prognostic value of procalcitonin in patients after elective cardiac surgery: a prospective cohort study.

Authors:  Matthias Klingele; Hagen Bomberg; Simone Schuster; Hans-Joachim Schäfers; Heinrich Volker Groesdonk
Journal:  Ann Intensive Care       Date:  2016-11-23       Impact factor: 6.925

5.  Value of procalcitonin as a biomarker for postoperative hospital-acquired pneumonia after abdominal surgery.

Authors:  Mohamed M Abu Elyazed; Maysaa El Sayed Zaki
Journal:  Korean J Anesthesiol       Date:  2017-01-12

6.  Combination of S100B and procalcitonin improves prognostic performance compared to either alone in patients with cardiac arrest: A prospective observational study.

Authors:  Jae Ho Jang; Won Bin Park; Yong Su Lim; Jea Yeon Choi; Jin Seong Cho; Jae-Hyug Woo; Woo Sung Choi; Hyuk Jun Yang; Sung Youl Hyun
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

7.  Usefulness of coronary flow reserve measured by transthoracic coronary Doppler ultrasound in the elderly.

Authors:  Danijela Trifunovic; Edina Cenko; Concetta Torromeo; Beatrice Ricci; Michele Schiariti; Marija Zdravkovic; Zorana Vasiljevic; Olivia Manfrini
Journal:  J Geriatr Cardiol       Date:  2017-07       Impact factor: 3.327

8.  Coronary heart disease incidence and competing risks: an important issue.

Authors:  Paolo Emilio Puddu; Peter Louis Amaduzzi; Beatrice Ricci
Journal:  J Geriatr Cardiol       Date:  2017-07       Impact factor: 3.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.